FI960027A0 - Yhdisteitä, joilla on hCG:n antigeenisuus - Google Patents

Yhdisteitä, joilla on hCG:n antigeenisuus

Info

Publication number
FI960027A0
FI960027A0 FI960027A FI960027A FI960027A0 FI 960027 A0 FI960027 A0 FI 960027A0 FI 960027 A FI960027 A FI 960027A FI 960027 A FI960027 A FI 960027A FI 960027 A0 FI960027 A0 FI 960027A0
Authority
FI
Finland
Prior art keywords
hcg
antigenicity
compounds
hcg antigenicity
Prior art date
Application number
FI960027A
Other languages
English (en)
Swedish (sv)
Other versions
FI960027A (fi
Inventor
James N Herron
Original Assignee
Univ Utah Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Utah Res Found filed Critical Univ Utah Res Found
Publication of FI960027A publication Critical patent/FI960027A/fi
Publication of FI960027A0 publication Critical patent/FI960027A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
FI960027A 1993-07-06 1996-01-03 Yhdisteitä, joilla on hCG:n antigeenisuus FI960027A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/089,994 US5380668A (en) 1993-07-06 1993-07-06 Compounds having the antigenicity of hCG
PCT/US1994/007605 WO1995001993A1 (en) 1993-07-06 1994-07-06 COMPOUNDS HAVING THE ANTIGENICITY OF hCG

Publications (2)

Publication Number Publication Date
FI960027A FI960027A (fi) 1996-01-03
FI960027A0 true FI960027A0 (fi) 1996-01-03

Family

ID=22220572

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960027A FI960027A0 (fi) 1993-07-06 1996-01-03 Yhdisteitä, joilla on hCG:n antigeenisuus

Country Status (8)

Country Link
US (1) US5380668A (fi)
EP (1) EP0708784A1 (fi)
JP (1) JPH08512325A (fi)
KR (1) KR960703942A (fi)
AU (1) AU698501B2 (fi)
CA (1) CA2166385A1 (fi)
FI (1) FI960027A0 (fi)
WO (1) WO1995001993A1 (fi)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919712A (en) 1993-05-18 1999-07-06 University Of Utah Research Foundation Apparatus and methods for multi-analyte homogeneous fluoro-immunoassays
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US5997871A (en) * 1996-06-24 1999-12-07 University Of Maryland Biotechnology Insitute Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
US5968513A (en) * 1996-06-24 1999-10-19 University Of Maryland Biotechnology Institute Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin
US6583109B1 (en) 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
US6844315B2 (en) * 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
US20050227925A1 (en) * 2004-04-08 2005-10-13 Robbert Benner Compositions capable of reducing elevated blood urea concentration
US7175679B2 (en) * 2001-03-29 2007-02-13 Biotempt B.V. Oligopeptide treatment of NF-κB mediated inflammation
US20040202645A1 (en) * 2003-04-08 2004-10-14 Khan Nisar Ahmed Administration of gene-regulatory peptides
US6921751B1 (en) 1998-05-20 2005-07-26 Erasmus Universiteit Rotterdam Immunoregulator
US20030220258A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
EP1138692A1 (en) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragments of human chorionic gonadotropin (hcg) as immunoregulator
US8680059B2 (en) * 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US7994278B1 (en) 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
EP1300418A1 (en) 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
US20050037430A1 (en) * 2000-03-29 2005-02-17 Biotempt B.V. Methods and uses for protein breakdown products
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
US7576174B2 (en) * 2000-03-29 2009-08-18 Biotempt B.V. Compositions capable of reducing elevated blood urea concentration
CN1172717C (zh) * 2000-08-18 2004-10-27 清华大学 一种治疗艾滋病的药物及其制备方法
US7326536B2 (en) * 2001-05-03 2008-02-05 Eli Lilly And Company Agents for treatment of HCV and methods of use
FR2827170B1 (fr) * 2001-07-13 2004-07-16 Soc Extraction Principes Actif Utilisation de peptides pour augmenter l'adhesion cellulaire
US20030220259A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of neurological disorders
US20030108563A1 (en) * 2001-11-07 2003-06-12 Chander Bahl Reagents for the simultaneous detection of HCV core antigens and antibodies
US20080242837A1 (en) * 2001-12-21 2008-10-02 Khan Nisar A Peptide compositions
US20040013661A1 (en) * 2001-12-21 2004-01-22 Gert Wensvoort Stratification
US7560433B2 (en) * 2001-12-21 2009-07-14 Biotempt B.V. Treatment of multiple sclerosis (MS)
US7501391B2 (en) * 2001-12-21 2009-03-10 Biotempt B.V. Treatment of transplant survival
US20030220257A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of trauma
US7786084B2 (en) * 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US20030224995A1 (en) * 2001-12-21 2003-12-04 Khan Nisar Ahmed Treatment of burns
US20030220260A1 (en) * 2001-12-21 2003-11-27 Khan Nisar Ahmed Peptide compositions
US20030220261A1 (en) * 2001-12-21 2003-11-27 Khan Nisar Ahmed Treatment of iatrogenic disease
US20080318871A1 (en) * 2001-12-21 2008-12-25 Khan Nisar A Treatment of neurological disorders
US7517529B2 (en) * 2003-04-08 2009-04-14 Biotempt B.V. Treatment of type I diabetes
US7625542B2 (en) * 2003-04-25 2009-12-01 Inframat Corporation Method for the production of metal carbides
US20090227505A1 (en) * 2004-01-07 2009-09-10 Biotempt B.V. Methods and uses for protein breakdown products
JP4846799B2 (ja) * 2005-07-05 2011-12-28 バイオテンプト ベー．フェー． 腫瘍の治療
EP1864692A1 (en) * 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
AU2008215193B2 (en) * 2007-02-12 2014-01-16 Biotempt B.V. Treatment of trauma hemorrhage with short oligopeptides
EP2109054A1 (en) 2008-04-09 2009-10-14 Biotempt B.V. Methods for identifying biologically active peptides and predicting their function
EP2490021A1 (en) 2011-02-18 2012-08-22 Biotempt B.V. Modulators of PRR and GPCR signalling

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071314A (en) * 1973-01-08 1978-01-31 Laboratoire Theranol Processes, reagents and means for early diagnosis of pregnancy
US4116776A (en) * 1976-04-19 1978-09-26 International Radioimmune Systems, Inc. Diagnostic blood test and kit for detecting human chorionic gonadotropin
JPS5781447A (en) * 1980-11-11 1982-05-21 Toyo Jozo Co Ltd Human chorionic gonadotropic hormone c-terminal fragment
CA1247080A (en) * 1983-03-08 1988-12-20 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
CA1255586A (en) * 1984-07-24 1989-06-13 Hendrik M. Geysen Method of determining mimotopes
NZ215865A (en) * 1985-04-22 1988-10-28 Commw Serum Lab Commission Method of determining the active site of a receptor-binding analogue
US4789734A (en) * 1985-08-06 1988-12-06 La Jolla Cancer Research Foundation Vitronectin specific cell receptor derived from mammalian mesenchymal tissue
US4804626A (en) * 1986-10-22 1989-02-14 The General Hospital Corporation Immunometric assay for the detection of human chorionic gonadotropin
GB8701432D0 (en) * 1987-01-22 1987-02-25 Unilever Plc Assays
CA2047191A1 (en) * 1989-02-17 1990-08-18 Hendrik M. Geysen Method for the use and synthesis of peptides

Also Published As

Publication number Publication date
CA2166385A1 (en) 1995-01-19
FI960027A (fi) 1996-01-03
KR960703942A (ko) 1996-08-31
JPH08512325A (ja) 1996-12-24
AU7324494A (en) 1995-02-06
US5380668A (en) 1995-01-10
WO1995001993A1 (en) 1995-01-19
EP0708784A1 (en) 1996-05-01
AU698501B2 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
FI960027A0 (fi) Yhdisteitä, joilla on hCG:n antigeenisuus
TR28005A (tr) Izopren-butadienli kaucuk.
FI896179A0 (fi) Lagerbestaendiga, synnerligen poroesa, kalorifattiga livsmedelsprodukter.
FI923072A0 (fi) Maongstegsbindemedel foer anvaendning i elastomerbelaeggningar, mastixbelaeggningar, dikt- och taetningsmedel.
FI933980A0 (fi) Skyddsplagg foer hygienkraevande objekt, saosom operationssalar
TR27962A (tr) Ikame edilmis 2-aril-oksazinler ve -tiyazinler.
FR2702259B1 (fr) Viscocoupleur.
FI923542A0 (fi) Faestanordning foer klingor, isynnerhet i bestrykningsmaskiner.
ITMI931785A0 (it) Valilamidi di 7x-amino-1, 1-dioxo-cefem
FR2713451B1 (fr) Pince - accroche - canne.
FI930961A0 (fi) Matstation foer koettboskap, saerskilt svin
ES1024502Y (es) Contenedor-expositor.
FR2706039B1 (fr) Logomètre.
ES1026744Y (es) Banderilla.
ES1024679Y (es) Visera-pañoleta.
FI933095A0 (fi) Nyckel, saerskilt staellbar nyckel
FI931443A0 (fi) Nyckelloest, osynligt saekerhetslaos
FI932663A0 (fi) Presenning, saosom byggnadspresenning
FI931133A0 (fi) Eldslaeckningsmedel, eldslaeckningsmedelblandning
FI930249A0 (fi) Vattentaet, sjaelvlaosande, laett oeppningsbar inspektionslucka (brunnslock)
FI931776A0 (fi) Kotelo, kuten laitekotelo
FI930868A0 (fi) Vindfoerstyvning foer paraplyer, parasoller eller liknande skydd
FI900674A (fi) Skruvfraes, saerskilt dikesfraes.
ES1024033Y (es) Dispositivo luminoso perfeccionado, aplicable en calzados.
ES1024172Y (es) Frasco con tapon-precinto.

Legal Events

Date Code Title Description
FD Application lapsed